Other study related to crosstalk between melatonin and growth factors signaling pathway in cancer, is done by Marques et al.; in that study it is seen melatonin suppresses angiogenic features of triple negative breast cancer cells by inhibiting expression of IGF-IR, HIF-1α and VEGF proteins through regulation of miRNA-152-3p [144]. This evidence concerns the gene IGF1R and cancer.